Lise Hébert
Chief Tech/Sci/R&D Officer bij KLOX TECHNOLOGIES INC
Profiel
Lise Hébert is currently the Director, EVP-Research & Clinical Affairs at KLOX Technologies, Inc. and also holds the position of Director at FB Dermatology Ltd.
In the past, she worked as the Executive Director at Fédération des Sociétés Alzheimer du Québec and as the Vice President-Corporate Communications at BELLUS Health, Inc. Dr. Hébert holds a doctorate degree from McGill University.
Actieve functies van Lise Hébert
| Bedrijven | Functie | Begin |
|---|---|---|
| KLOX TECHNOLOGIES INC | Chief Tech/Sci/R&D Officer | - |
FB Dermatology Ltd.
 FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland. | Director/Board Member | - |
Eerdere bekende functies van Lise Hébert
| Bedrijven | Functie | Einde |
|---|---|---|
Fédération des Sociétés Alzheimer du Québec
 Fédération des Sociétés Alzheimer du Québec Investment ManagersFinance Fédération des Sociétés Alzheimer du Québec is a private company based in Montréal, Canada. | Director/Board Member | - |
| BELLUS HEALTH | Public Communications Contact | - |
Opleiding van Lise Hébert
| McGill University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Fédération des Sociétés Alzheimer du Québec
Fédération des Sociétés Alzheimer du Québec Investment ManagersFinance Fédération des Sociétés Alzheimer du Québec is a private company based in Montréal, Canada. | Finance |
KLOX Technologies, Inc.
 KLOX Technologies, Inc. Medical SpecialtiesHealth Technology KLOX Technologies, Inc. designs and develops therapeutic and cosmetic products. The firm offers fluorescence biomodulation technology. The company was founded by Francesco Bellini in 2007 and is headquartered in Laval, Canada. | Health Technology |
FB Dermatology Ltd.
FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland. | Health Technology |
